/ Health
Illuminating the Emotions & Needs of a Rare Disease
The Challenge
Patients with this rare disease often find themselves relying on high doses of an OTC medication that fails to fully alleviate their symptoms, instead of moving to an injectable prescription. Egg was assigned the task of helping the company identify ways to facilitate an earlier transition to injectable treatments for these patients.
Path Forward
Egg uncovered deep emotive insights about living with this rare disease and barriers to transitioning to a prescription by utilizing a four-prong approach of interviews with brand ambassadors, an online community, follow-up virtual IDIs, and in-home interviews.
Impact
These patients are continuously striving to find balance in both their treatment and their lives. However, four key barriers prevent them from breaking free of the unstable cycle of relying on OTC medications. By identifying these barriers and demonstrating how patients using the injectable prescription overcome them, we highlighted opportunities and provided recommendations on how the company can support a smoother transition to the prescription treatment at an earlier stage.